ResMed | RMD - Ebit

Stock Price
201.88
Daily Change
-0.58 -0.29%
Monthly
-10.16%
Yearly
-19.79%
Q2 Forecast
197.82

ResMed reported $505.67M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Ansell USD 146.5M 29.2M Dec/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Cochlear AUD 261.1M 13.9M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
CSL USD 2.64B 116M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 13.71M Dec/2025
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Philips EUR 302M 417M Mar/2026
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Steris USD 318.7M 40.7M Mar/2026
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026